Comparison Chart Pacific Biosciences of California, Inc.
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 1.630 USD | -7.39% |
|
-16.84% | -12.83% |
| 11-09 | UBS Adjusts Price Target on Pacific Biosciences of California to $2.70 From $3.05, Maintains Neutral Rating | MT |
| 11-04 | Pacific Biosciences of California, Inc., Q3 2026 Earnings Call, Nov 04, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Other Advanced Medical Equipment & Technology | -7.39% | -16.84% | -12.83% | -26.58% | -93.84% | 510M |
Select your edition
All financial news and data tailored to specific country editions
















